HPV vaccine program study in Cameroon
Part of Infections clinical trials.
This study looks at how to best offer the HPV vaccine in Cameroon. It interviews key people who help run or know about the program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a key informant chosen by the study team.
- You must give written consent to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is interviewing girls ages 9 to 14 and their caregivers in Ethiopia to learn how to better integrate HPV vaccination into routine health services. If you received an HPV vaccine or other VYA service on the day you were recruited, you may be able to share your experience.
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
Hear when a new Papillomavirus Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.